Lee Heeson

Lee Heeson

Company: Celgene Corporation

Job title: President - Worldwide Markets, Inflammation & Immunology

Bio:

Lee Heeson assumes the responsibility for the commercial operations for the Inflammation & Immunology franchise at Celgene, a global biopharmaceutical company focusing on the discovery, development and commercialization of products for the treatment of cancer and other severe, immune, inflammatory conditions. While Lee’s primary responsibility is to ensure the successful commercialization of Celgene’s therapies in the inflammation and immunology space, Lee is keen on working collaboratively with all stakeholders on innovative solutions to overcome the challenges of our health systems and ensure that every patient has access to the right therapy at the right time. Prior to his current role, Lee has held several leadership positions in various pharmaceutical companies, working across multiple therapeutic areas and geographies, including Europe, Latin America, the United States and Japan.

Seminars:

Panel Discussion: The Evolving Clinical, Regulatory & Commercial Paradigm in Dermatology 10:45 am

• Exploring how to overcome key challenges in dermatology clinical development • Assessing the need for cooperation between regulators, payers and drug developers in the definition of appropriate endpoints in the development of therapies targeting rare diseases • Supporting value-based evidence to external stakeholders – establishing the value of new therapies and effectively demonstrating improved…Read more

day: Day Two

Begin with the End in Mind 9:30 am

• Making choices – assessing the unmet needs across dermatology • Understanding the future dermatology pricing and reimbursement dynamics in Europe • Demonstrating clinical value against outdated regulatory endpoints – growing utility of Real World Evidence (Payers & Clinicians)Read more

day: Day Two

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.